{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:12:25Z","timestamp":1785420745465,"version":"3.56.0"},"reference-count":94,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chauvell, LLC"},{"id":[{"id":"https:\/\/ror.org\/04bd74a48","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Microbiome-targeted interventions have shown promise for metabolic health, yet clinical evidence remains inconsistent, particularly across stages of metabolic disease. This study evaluated the metabolic effects, safety, and tolerability of EDC-HHA01, a microbiome-informed, non-pharmacologic intervention, in adults with prediabetes (PD) or Type 2 Diabetes (T2DM). In a randomized, double-blind, placebo-controlled clinical trial, participants received EDC-HHA01 or placebo for six months. The study was adequately powered (\u226580%) for the primary endpoint. Outcomes included changes in glycated hemoglobin (HbA1c), indices of insulin resistance, markers of metabolic endotoxemia, safety-related laboratory parameters, and exploratory patient-reported measures. Analyses were stratified by metabolic status and background metformin use. In participants with PD, EDC-HHA01 supplementation was associated with a statistically and clinically meaningful reduction in HbA1c compared with placebo, supported by concordant improvements in fasting insulin, insulin resistance indices, and reductions in endotoxemia markers. In participants with T2DM, changes were directionally similar but attenuated and did not reach statistical significance. The intervention was well tolerated, with no serious adverse events, high adherence, and no clinically relevant adverse changes in renal or lipid parameters. Exploratory patient-reported outcomes indicated favorable acceptability but were not interpreted as efficacy endpoints. EDC-HHA01 was associated with biologically coherent, stage-dependent metabolic effects, most evident in PD. These findings support further investigation of microbiome-informed strategies as metabolic support in early-stage dysregulation.<\/jats:p>","DOI":"10.3390\/microorganisms14040749","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:33:33Z","timestamp":1774622013000},"page":"749","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of the Synbiotic Formulation EDC-HHA01 on Glucose Regulation in Adults with Type 2 Diabetes and Prediabetes: A Randomized, Placebo-Controlled Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9851-2041","authenticated-orcid":false,"given":"Gissel","family":"Garc\u00eda","sequence":"first","affiliation":[{"name":"Pathology Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San L\u00e1zaro No. 701, Esquina a Belascoa\u00edn, La Habana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0454-9315","authenticated-orcid":false,"given":"Mar\u00eda del Carmen","family":"Campos","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San L\u00e1zaro No. 701, Esquina a Belascoa\u00edn, La Habana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josanne","family":"Soto","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San L\u00e1zaro No. 701, Esquina a Belascoa\u00edn, La Habana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3652-5661","authenticated-orcid":false,"given":"Antonio","family":"Diaz","sequence":"additional","affiliation":[{"name":"Statistical and Research Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San L\u00e1zaro No. 701, Esquina a Belascoa\u00edn, La Habana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Buchaca","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San L\u00e1zaro No. 701, Esquina a Belascoa\u00edn, La Habana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9652-8878","authenticated-orcid":false,"given":"Duniesky","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Research and Development Department, Center for Genetic Engineering and Biotechnology of Sancti Sp\u00edritus, Circunvalante Norte, Reparto Olivos 3, Sancti Spiritus 60200, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirka","family":"Bernal","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San L\u00e1zaro No. 701, Esquina a Belascoa\u00edn, La Habana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Escobar","sequence":"additional","affiliation":[{"name":"Nutrition Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San L\u00e1zaro No. 701, Esquina a Belascoa\u00edn, La Habana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lais","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San L\u00e1zaro No. 701, Esquina a Belascoa\u00edn, La Habana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Vald\u00e9s","sequence":"additional","affiliation":[{"name":"Nutrition Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San L\u00e1zaro No. 701, Esquina a Belascoa\u00edn, La Habana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricela","family":"Nuez","sequence":"additional","affiliation":[{"name":"Nutrition Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San L\u00e1zaro No. 701, Esquina a Belascoa\u00edn, La Habana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noraika","family":"Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San L\u00e1zaro No. 701, Esquina a Belascoa\u00edn, La Habana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9964-0378","authenticated-orcid":false,"given":"Liuvob","family":"Sichel","sequence":"additional","affiliation":[{"name":"Stellar Biotics, LLC, Rockleigh, 22 Paris Ave, Suite 209, Rockleigh, NJ 07647, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6888-5018","authenticated-orcid":false,"given":"Ra\u00fal de Jes\u00fas","family":"Cano","sequence":"additional","affiliation":[{"name":"Biological Sciences Department, California Polytechnic State University, San Luis Obispo, CA 93405, USA"},{"name":"Chauvel, LLC, San Luis Obispo, CA 93405, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee, ElSayed, N.A., Aleppo, G., Bannuru, R.R., Beverly, E.A., Bruemmer, D., Collins, B.S., Cusi, K., Darville, A., and Das, S.R. (2023). Introduction and Methodology: Standards of Care in Diabetes\u20142024. Diabetes Care, 47, S1\u2013S4.","DOI":"10.2337\/dc24-SINT"},{"key":"ref_2","unstructured":"World Health Organization (2026, January 02). World Diabetes Day 2024: Breaking Barriers, Bridging Gaps. Available online: https:\/\/www.who.int\/campaigns\/world-diabetes-day\/2024."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee, ElSayed, N.A., McCoy, R.G., Aleppo, G., Balapattabi, K., Beverly, E.A., Early, K.B., Bruemmer, D., Ebekozien, O., and Echouffo-Tcheugui, J.B. (2024). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142025. Diabetes Care, 48, S27\u2013S49.","DOI":"10.2337\/dc25-S002"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2337\/dc22-2376","article-title":"Global Prevalence of Prediabetes","volume":"46","author":"Rooney","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature18846","article-title":"Diet\u2013microbiota interactions as moderators of human metabolism","volume":"535","author":"Sonnenburg","year":"2016","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","article-title":"Microbiota and diabetes: An evolving relationship","volume":"63","author":"Tilg","year":"2014","journal-title":"Gut"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Fliegerov\u00e1, K.O., Mahayri, T.M., Sechovcov\u00e1, H., Mekadim, C., Mr\u00e1zek, J., Jaro\u0161\u00edkov\u00e1, R., Dubsk\u00fd, M., and Fejfarov\u00e1, V. (2025). Diabetes and gut microbiome. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1451054"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/ITT.S499605","article-title":"Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: Implications for therapeutic interventions","volume":"14","author":"Berbudi","year":"2025","journal-title":"ImmunoTargets Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1515\/mr-2025-0047","article-title":"Interplay between aging and metabolic diseases: From molecular mechanisms to therapeutic horizons","volume":"5","author":"Zhong","year":"2025","journal-title":"Med. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: A high-risk state for diabetes development","volume":"379","author":"Herder","year":"2012","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: Implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_13","first-page":"270","article-title":"Metabolic Shifting Probiotic in Type 2 Diabetes Mellitus Management: Randomized Clinical Trial","volume":"6","author":"Soto","year":"2023","journal-title":"J. Biotechnol. Biomed."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Garc\u00eda, G., Soto, J., Netherland, M., Hasan, N.A., Buchaca, E., Mart\u00ednez, D., Carlin, M., and de Jesus Cano, R. (2024). Evaluating the Effects of Sugar Shift(\u00ae) Symbiotic on Microbiome Composition and LPS Regulation: A Double-Blind, Placebo-Controlled Study. Microorganisms, 12.","DOI":"10.3390\/microorganisms12122525"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40618-016-0576-8","article-title":"Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight\/obesity","volume":"40","author":"Pacifico","year":"2017","journal-title":"J. Endocrinol. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.33314\/jnhrc.v17i4.1042","article-title":"The Declaration of Helsinki on Medical Research involving Human Subjects: A Review of Seventh Revision","volume":"17","author":"Shrestha","year":"2020","journal-title":"J. Nepal Health Res. Counc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1021\/acs.analchem.6b00188","article-title":"Power analysis and sample size determination in metabolic phenotyping","volume":"88","author":"Blaise","year":"2016","journal-title":"Anal. Chem."},{"key":"ref_18","unstructured":"Christiansen, T.L.J., and Lauritsen, J.M. (2010). EpiData\u2014Comprehensive Data Management and Basic Statistical Analysis System, EpiData Association. Available online: http:\/\/www.epidata.dk."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","article-title":"CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials","volume":"10","author":"Moher","year":"2012","journal-title":"Int. J. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"D575","DOI":"10.1093\/nar\/gkaa746","article-title":"The ModelSEED Database for the integration of metabolic annotations and the reconstruction, comparison, and analysis of metabolic models for plants, fungi, and microbes","volume":"49","author":"Seaver","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_21","unstructured":"Farnworth, E.R. (2016). 17 Probiotics and Prebiotics. Handbook of Nutraceuticals and Functional Foods, CRC Press."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Shenderov, B.A., Sinitsa, A.V., Zakharchenko, M., and Lang, C. (2020). Metabiotics, Springer.","DOI":"10.1007\/978-3-030-34167-1"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.15673\/fst.v18i2.2903","article-title":"Immunomodulatory activity of the lactobacillus delbrueckii subsp. Bulgaricus lb 86 enzyme lysate","volume":"18","author":"Lazarenko","year":"2024","journal-title":"Food Sci. Technol."},{"key":"ref_24","unstructured":"D\u00edaz Machado, A., Campos Castillo, M.d.C., Soto Matos, J., Garc\u00eda Men\u00e9ndez, G., and Cano Chauvell, R.J. (2025). Entrevista semiestructurada para estudios de seguridad en probi\u00f3ticos y suplementos alimenticios. Acta M\u00e9dica, 26."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13690-015-0088-6","article-title":"Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis","volume":"73","author":"Ketema","year":"2015","journal-title":"Arch. Public Health"},{"key":"ref_26","first-page":"1548","article-title":"The role of gut microbiota in mediating obesity and diabetes mellitus","volume":"24","author":"Pitocco","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0140-6736(25)00672-5","article-title":"CONSORT 2025 statement: Updated guideline for reporting randomised trials","volume":"405","author":"Hopewell","year":"2025","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/opo.12131","article-title":"When to use the Bonferroni correction","volume":"34","author":"Armstrong","year":"2014","journal-title":"Ophthalmic Physiol. Opt. J. Br. Coll. Ophthalmic Opt."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.37843\/rted.v17i2.554","article-title":"Importancia de Conocer la Normalidad de los Datos Utilizados en los Trabajos de Investigaci\u00f3n por Tesistas","volume":"17","year":"2024","journal-title":"Rev. Docentes 2.0"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1177\/13623613251334166","article-title":"Demographic, ecological and social predictors of quality of life among parents of autistic children: A multi-centre cross-sectional study","volume":"29","author":"Saleem","year":"2025","journal-title":"Autism"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.29262\/ram.v658i2.949","article-title":"M\u00e9todos estad\u00edsticos para el an\u00e1lisis del tama\u00f1o del efecto","volume":"68","year":"2021","journal-title":"Rev. Alerg. M\u00e9x."},{"key":"ref_34","unstructured":"Jos\u00e9, U. (2021). Python Programming for Data Analysis, Springer."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Sci. Eng."},{"key":"ref_36","unstructured":"Leyder, S., Raymaekers, J., Rousseeuw, P.J., Servotte, T., and Verdonck, T. (2024). RobPy: A Python Package for Robust Statistical Methods. arXiv."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Bisong, E. (2019). Google colaboratory. Building Machine Learning and Deep Learning Models on Google Cloud Platform: A Comprehensive Guide for Beginners, Springer.","DOI":"10.1007\/978-1-4842-4470-8"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1037\/0033-2909.114.3.494","article-title":"Dominance statistics: Ordinal analyses to answer ordinal questions","volume":"114","author":"Cliff","year":"1993","journal-title":"Psychol. Bull."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Rajagopalan, G. (2021). A Python Data Analyst\u2019s Toolkit: Learn Python and Python-based Libraries with Applications in Data Analysis and Statistics, Springer.","DOI":"10.1007\/978-1-4842-6399-0"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.12688\/wellcomeopenres.15191.2","article-title":"Raincloud plots: A multi-platform tool for robust data visualization","volume":"4","author":"Allen","year":"2021","journal-title":"Wellcome Open Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/advances\/nmy046","article-title":"Perspective: Fundamental limitations of the randomized controlled trial method in nutritional research: The example of probiotics","volume":"9","author":"Zeilstra","year":"2018","journal-title":"Adv. Nutr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1080\/10408398.2023.2169858","article-title":"Commercial probiotic products in public health: Current status and potential limitations","volume":"64","author":"Liang","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ghosh, S., Singh, K.K., Raghunath, M., and Sinha, J.K. (2025). Clinical Trials and Evidence-Based Nutraceutical Interventions. Rejuvenating the Brain: Nutraceuticals, Autophagy, and Longevity, Springer.","DOI":"10.1007\/978-981-95-2790-8_15"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12933-023-01898-1","article-title":"Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: A retrospective study","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"A471","DOI":"10.1016\/j.jval.2011.08.1298","article-title":"PCN199 An Evaluation of Statistical Methods Used to Analyse Patient-Reported Outcomes (PRO) Data in Published Metastatic Cancer Studies","volume":"14","author":"Gilet","year":"2011","journal-title":"Value Health"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/pmrj.12980","article-title":"Exploratory analyses: How to meaningfully interpret and report them","volume":"15","author":"Roberts","year":"2023","journal-title":"PMR J. Inj. Funct. Rehabil."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","article-title":"Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: Results of a questionnaire-based study","volume":"7","author":"Basch","year":"2006","journal-title":"Lancet Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.molonc.2014.07.025","article-title":"Early phase clinical trials to identify optimal dosing and safety","volume":"9","author":"Cook","year":"2015","journal-title":"Mol. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/diacare.27.7.1761","article-title":"Tests of glycemia in diabetes","volume":"27","author":"Goldstein","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/dc08-0545","article-title":"Translating the A1C assay into estimated average glucose values","volume":"31","author":"Nathan","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.2017.10169","article-title":"Effect of an intensive lifestyle intervention on glycemic control in patients with type 2 diabetes: A randomized clinical trial","volume":"318","author":"Johansen","year":"2017","journal-title":"JAMA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.joim.2024.01.007","article-title":"Predictors of the placebo response in a nutraceutical randomized controlled trial for depression","volume":"22","author":"Arnold","year":"2024","journal-title":"J. Integr. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5455\/jice.20150403055054","article-title":"The subtle central effect of nutraceuticals: Is it placebo or nocebo?","volume":"4","year":"2015","journal-title":"J. Intercult. Ethnopharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"Group","year":"1998","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc09-1407","article-title":"Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial","volume":"33","author":"Rowan","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat. Med."},{"key":"ref_57","first-page":"118","article-title":"Dual-edged health benefit of Akkermansia muciniphila: Impact on metformin and insulin resistance in type 2 diabetes\u2013A perspective","volume":"4","author":"Rajpurohit","year":"2024","journal-title":"Curr. Top. Diabetes"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Mierlan, O.L., Busila, C., Amaritei, O., Elena, D., Raileanu, C.R., Maftei, N.-M., Matei, M.N., and Gurau, G. (2025). Akkermansia muciniphila in Metabolic Disease: Far from Perfect. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262311602"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Omeragi\u0107, E., Imamovi\u0107, B., Be\u010di\u0107, E., Dedi\u0107, M., and Hashemi, F. (2024). Modulating the human microbiome: The impact of xenobiotics on gut microbial composition and therapeutic strategies. Human Microbiome: Techniques, Strategies, and Therapeutic Potential, Springer.","DOI":"10.1007\/978-981-97-3790-1_19"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cell.2016.04.007","article-title":"Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans","volume":"165","author":"Vatanen","year":"2016","journal-title":"Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ismej.2009.112","article-title":"Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice","volume":"4","author":"Zhang","year":"2010","journal-title":"ISME J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_65","first-page":"157","article-title":"Effects of lifestyle interventions on glucose regulation and diabetes risk in adults with impaired glucose tolerance or prediabetes: A meta-analysis","volume":"66","author":"Jiang","year":"2022","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"103475","DOI":"10.1016\/j.ebiom.2021.103475","article-title":"Early-life gut microbiota and its connection to metabolic health in children: Perspective on ecological drivers and need for quantitative approach","volume":"69","author":"Jian","year":"2021","journal-title":"EBioMedicine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.metabol.2016.12.009","article-title":"Metabolic endotoxemia and diabetes mellitus: A systematic review","volume":"68","author":"Gomes","year":"2017","journal-title":"Metabolism"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e24029","DOI":"10.1016\/j.heliyon.2024.e24029","article-title":"Advances in crosstalk among innate immune pathways activated by mitochondrial DNA","volume":"10","author":"Tao","year":"2024","journal-title":"Heliyon"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e14224","DOI":"10.1111\/eci.14224","article-title":"The relevance of intestinal barrier dysfunction, antimicrobial proteins and bacterial endotoxin in metabolic dysfunction-associated steatotic liver disease","volume":"54","author":"Bergheim","year":"2024","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/gutjnl-2020-323617","article-title":"Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: A 24-week, double-blind, randomised controlled trial","volume":"71","author":"Ng","year":"2022","journal-title":"Gut"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Zhu, X., Yu, X., Nov\u00e1k, P., Gui, Q., and Yin, K. (2023). Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1120168"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pharmthera.2011.01.012","article-title":"The gut microbiome as therapeutic target","volume":"130","author":"Cani","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Janiad, S., and Rehman, K. (2024). Microbiome-Targeted Therapies: Enhancing Resilience in Metabolic Disorders. Human Microbiome: Techniques, Strategies, and Therapeutic Potential, Springer.","DOI":"10.1007\/978-981-97-3790-1_13"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13679-025-00673-5","article-title":"Beyond Discrete Diagnoses: Conceptualizing Obesity-associated Metabolic Disorders as a Unified, Dynamic Continuum","volume":"14","author":"Xie","year":"2025","journal-title":"Curr. Obes. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"McCarney, R., Warner, J., Iliffe, S., Van Haselen, R., Griffin, M., and Fisher, P. (2007). The Hawthorne Effect: A randomised, controlled trial. BMC Med. Res. Methodol., 7.","DOI":"10.1186\/1471-2288-7-30"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13073-016-0300-5","article-title":"Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: A systematic review of randomized controlled trials","volume":"8","author":"Kristensen","year":"2016","journal-title":"Genome Med."},{"key":"ref_80","first-page":"CD003974","article-title":"Placebo interventions for all clinical conditions","volume":"2010","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.2018.11025","article-title":"The challenge of reforming nutritional epidemiologic research","volume":"320","author":"Ioannidis","year":"2018","journal-title":"JAMA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","article-title":"Variations in patients\u2019 adherence to medical recommendations: A quantitative review of 50 years of research","volume":"42","author":"DiMatteo","year":"2004","journal-title":"Med. Care"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/dom.13160","article-title":"Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and meta-analysis","volume":"20","author":"McGovern","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Teixeira, P.J., Carra\u00e7a, E.V., Marques, M.M., Rutter, H., Oppert, J.-M., De Bourdeaudhuij, I., Lakerveld, J., and Brug, J. (2015). Successful behavior change in obesity interventions in adults: A systematic review of self-regulation mediators. BMC Med., 13.","DOI":"10.1186\/s12916-015-0323-6"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Enck, P., and Klosterhalfen, S. (2020). Placebo responses and placebo effects in functional gastrointestinal disorders. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.00797"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/09332480.2019.1579573","article-title":"Why most published research findings are false","volume":"32","author":"Ioannidis","year":"2019","journal-title":"Chance"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36)","volume":"30","author":"Framework","year":"1992","journal-title":"Med. Care"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Rudroff, T. (2025). Pharmacological and Non-pharmacological Interventions. Long COVID Fatigue: Clinical Sciences, Artificial Intelligence and the Future of Brain Health, Springer.","DOI":"10.1007\/978-3-031-89474-9"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2337\/diacare.6.5.472","article-title":"Diarrhea and metformin in a diabetic clinic","volume":"6","author":"Dandona","year":"1983","journal-title":"Diabetes Care"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Nabrdalik, K., Skonieczna-\u017bydecka, K., Irlik, K., Hendel, M., Kwiendacz, H., \u0141oniewski, I., Januszkiewicz, K., Gumprecht, J., and Lip, G.Y. (2022). Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.975912"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Lee, C.B., Chae, S.U., Jo, S.J., Jerng, U.M., and Bae, S.K. (2021). The relationship between the gut microbiome and metformin as a key for treating type 2 diabetes mellitus. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073566"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Wang, Y., Jia, X., and Cong, B. (2024). Advances in the mechanism of metformin with wide-ranging effects on regulation of the intestinal microbiota. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1396031"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Mukherjee, R., and Chang, C.M. (2025). Exploring the Ethical, Legal, and Societal Implications of Gut Microbiome Research in Metabolic Syndrome. Gut Health and Metabolic Syndrome, Springer.","DOI":"10.1007\/978-981-96-6246-3_10"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/4\/749\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:04:07Z","timestamp":1775059447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/4\/749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":94,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["microorganisms14040749"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms14040749","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]}}}